ENDOMETRIAL SARCOMA METASTATIC

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL SARCOMA METASTATIC:

# Drug Count
0 AMLODIPINE 1
1 DEXAMETHASONE 1
2 DEXAMETHASONE 1.5 MG 1
3 ECULIZUMAB 1
4 EQUINE THYMOCYTE IMMUNE GLOBULIN 1
5 EXEMESTANE 1
6 LETROZOLE 1
7 LETROZOLE TABLETS 1
8 LEUPROLIDE 1
9 LEUPROLIDE ACETATE 1
See all common drugs associated with ENDOMETRIAL SARCOMA METASTATIC

ENDOMETRIAL SARCOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EQUINE THYMOCYTE IMMUNE GLOBULIN 1 0.0010
1 SIROLIMUS 1 0.0001
2 EXEMESTANE 1 0.0000
3 LETROZOLE TABLETS 1 0.0000
4 ECULIZUMAB 1 0.0000
5 LETROZOLE 1 0.0000
6 LEUPROLIDE ACETATE 1 0.0000
7 RAMIPRIL 1 0.0000
8 AMLODIPINE 1 0.0000
9 DEXAMETHASONE 1.5 MG 1 0.0000
See all drugs enriched for association with ENDOMETRIAL SARCOMA METASTATIC

ENDOMETRIAL SARCOMA METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Complement Inhibitor [EPC] 1 0.0000
1 Aromatase Inhibitor [EPC] 2 0.0000
2 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
3 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
4 Kinase Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with ENDOMETRIAL SARCOMA METASTATIC